FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -92.4% | 91,864 | -82.9% | 0.01% | -91.9% |
| Q2 2023 | $2,555 | +17.8% | 536,831 | +41.1% | 0.11% | +8.8% |
| Q1 2023 | $2,169 | -99.7% | 380,537 | +1681.9% | 0.10% | +88.9% |
| Q1 2022 | $828,000 | +55.3% | 21,356 | +134.4% | 0.05% | -19.4% |
| Q4 2021 | $533,000 | +13.6% | 9,111 | +15.0% | 0.07% | +8.1% |
| Q3 2021 | $469,000 | +172.7% | 7,921 | -54.9% | 0.06% | +87.9% |
| Q1 2018 | $172,000 | -38.6% | 17,580 | -75.1% | 0.03% | -48.4% |
| Q3 2017 | $280,000 | -15.4% | 70,677 | -30.8% | 0.06% | -31.2% |
| Q2 2017 | $331,000 | – | 102,169 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |